A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
一项随机、双盲、平行组研究，旨在证明 CT-P13 与创新药物英夫利昔单抗联合使用甲氨蝶呤治疗活动性类风湿性关节炎患者的疗效和安全性相当：PLANETRA 研究
期刊:Annals of the Rheumatic Diseases
影响因子:20.3
doi:10.1136/annrheumdis-2012-203090
Dae Hyun Yoo, Pawel Hrycaj, Pedro Miranda, Edgar Ramiterre, Mariusz Piotrowski, Sergii Shevchuk, Volodymyr Kovalenko, Nenad Prodanovic, Mauricio Abello-Banfi, Sergio Gutierrez-Ureña, Luis Morales-Olazabal, Michael Tee, Renato Jimenez, Omid Zamani, Sang Joon Lee, HoUng Kim, Won Park, Ulf Müller-Ladne
